期刊文献+

视神经脊髓炎谱系疾病的临床特点及康复疗效分析 被引量:3

Clinical characteristics and rehabilitation effect of neuromyelitis spectrum diseases
下载PDF
导出
摘要 目的探讨视神经脊髓炎谱系疾病的临床特点与康复预后。方法回顾分析2016年1月~2018年10月中国康复研究中心北京博爱医院收治的7例诊断明确的视神经脊髓炎谱系疾病患者的临床资料,分析其临床特征及障碍点,观察日常生活活动(ADL)能力变化,比较康复预后情况。结果7例患者分别表现出不同程度的肢体运动功能障碍、感觉障碍、尿便障碍、视力异常以及情绪障碍,ADL均需介助。经系统、规范化康复治疗,患者功能障碍明显改善,ADL能力明显提高(P<0.01)。结论早期、积极的康复治疗能减轻患者的功能障碍,提高ADL能力。 Objective To investigate the clinical features and rehabilitation prognosis of neuromyelitis spectrum diseases.Methods The clinical data of 7 patients with diagnosed optic neuromyelitis spectrum disease admitted to China Rehabilitation Research Center,Beijing Boai Hospital from January 2016 to October 2018 were retrospectively analyzed,their clinical characteristics and obstacle points were analyzed,and changes in activity of daily living(ADL)ability were observed,and the rehabilitation prognosis was compared.Results The 7 patients showed different degrees of limb motor dysfunction,sensory dysfunction,urinary bowel disorder,abnormal vision and emotional disorder,all of which required ADL.After systematic and standardized rehabilitation treatment,patients′functional dysfunction and ADL ability were significantly improved(P<0.01).Conclusion Early and active rehabilitation therapy can reduce the dysfunction of patients and improve the ADL ability.
作者 刘平 何静杰 刘丽旭 胡雪艳 LIU Ping;HE Jingjie;LIU Lixu;HU Xueyan(Department of Neurorehabilitation,China Rehabilitation Research Center,Beijing Boai Hospital,Beijing100068,China)
出处 《中国医药导报》 CAS 2019年第24期185-188,F0003,共5页 China Medical Herald
关键词 视神经脊髓炎谱系疾病 水通道蛋白4 视神经炎 横贯性脊髓炎 康复治疗 Neuromyelitis optica spectrum disorder Aquaporin-4 Optic neuritis Transverse myelitis Rehabilitation treatment
  • 相关文献

参考文献2

二级参考文献39

  • 1Galetta SL, Bennett J. Neuromyelitis optica is a variant of multiple sclerosis[J]. Arch Neurol, 2007, 64: 901-903.
  • 2Lennon VA, Wingerehuk DM, Kryzer TJ, et al. A serum au- toantibody marker of neuromyelitis optica: distinction from multiple sclerosis[J]. Lancet, 2004, 364 : 2106-2112.
  • 3Wingerchuk DM, Lennon VA,Pittock SJ, et al. Revised diag- nostic criteria for neuromyelitis optiea[J]. Neurology, 2006, 66..1485-1489.
  • 4Saiz A, Zuliani L, Blanco Y, et al. Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients[J]. J Neurol, 2007, 254:1233-1237.
  • 5Waters P, Jarius S, Littleton E, et al. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis[J]. Arch Neurol, 2008, 65 : 913-919.
  • 6Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica[J].Lancet Neurol, 2007, 6..805-815.
  • 7Goulvestre C. Antinuclear antibodies[J]. Presse Med, 2006, 35,287-295.
  • 8Polman CH, Reingold SC, Edan G, et aI. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Crite- ria"[J]. Ann Neurol, 2005, 58: 840-846.
  • 9Weinshenker BG, Wingerchuk DM, Vukusic S, et al. Neuro- myelitis optica IgG predicts relapse after longitudinally exten- sive transverse myelitis[J]. Ann Neurol, 2006, 59:566-569.
  • 10Banwell B, Tenembaum S, Lennon VA, et al. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS dis- orders[J]. Neurology, 2008, 70:344-352.

共引文献11

同被引文献25

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部